Contemporary Results of Carotid Artery Stenting Using Low-Profile Dual-Metal Layer Nitinol Micromesh Stents in Relation to Single-Layer Carotid Stents
| Autor: | Luca Bertoglio, Andrea Kahlberg, Daniele Mascia, Vincenzo Ardita, Victor Bilman, Roberto Chiesa, Germano Melissano, Enrico Rinaldi |
|---|---|
| Přispěvatelé: | Kahlberg, Andrea, Bilman, Victor, Ardita, Vincenzo, Mascia, Daniele, Bertoglio, Luca, Rinaldi, Enrico, Melissano, Germano, Chiesa, Roberto |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Carotid arteries medicine.medical_treatment carotid artery disease Casper stent Roadsaver stent carotid stenosis carotid stenting dual-layer stent micromesh stents stroke Risk Factors Carotid artery disease Alloys medicine Humans Radiology Nuclear Medicine and imaging cardiovascular diseases Stroke Retrospective Studies business.industry Stent Perioperative medicine.disease Carotid Arteries Treatment Outcome Surgery Radiology Carotid stenting Cardiology and Cardiovascular Medicine business Single layer Carotid stents |
| Popis: | Purpose: To evaluate patients characteristics, procedural details, perioperative outcomes, and midterm results of carotid artery stenting (CAS) performed with the Roadsaver/Casper stent (Terumo Corp, Tokyo, Japan) as compared to concurrent patients treated with other commercially available carotid stents. Materials and Methods: This is a single-center, retrospective, nonrandomized study including 200 consecutive patients who underwent a total of 205 elective CAS procedures due to severe internal carotid artery stenosis between April 2015 and December 2018. Procedural data and outcomes for patients treated with the Roadsaver/Casper stent implantation (100 procedures, in 97 patients) vs first-generation carotid stents implantations (90 procedures, in 88 patients) were compared. Fifteen patients were treated with CGuard carotid stent (InspireMD, Tel Aviv, Israel), and outcomes were reported separately. Primary endpoints were the occurrence of major adverse cerebrovascular events (MACE), including death, ipsilateral stroke, and transitory ischemic attack (TIA). Secondary endpoints were the rate of intrastent stenosis, the need for reintervention, and the occurrence of adverse cardiovascular events, including myocardial infarction, arrhythmias, and need for inotropic support. Results: No difference in demographics and preoperative risk factors were observed between patients treated with and without the Roadsaver/Casper stent. The mean procedure time was shorter in the Roadsaver/Casper group (40.7±16.9 vs 49.4±27.3 minutes; p=0.008), while radial percutaneous access was more frequent (24% vs 5%; pConclusions: In this real-world cohort of patients undergoing CAS, the Roadsaver/Casper stent was used to treat more symptomatic and vulnerable carotid plaques as compared to other carotid stents. Nevertheless, patients treated with this low-profile dual-layer micromesh stent showed low events rates at both 30 days and follow-up, similar to that observed for other stents. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|